Comparing Plasmapheresis plus IVIg with Plasmapheresis plus IVIg plus Rituximab on the Management of Suspicious Antibody-Mediated Acute Rejection in Kidney Transplant Recipients

Comparing Plasmapheresis plus IVIg with Plasmapheresis plus IVIg plus Rituximab on the Management of Suspicious Antibody-Mediated Acute Rejection in Kidney Transplant Recipients

Background: There is no treatment of choice for the management of acute antibody-mediated rejection (ABMR) in kidney transplant recipients. Plasmapheresis ± intravenous immunoglobulin (IVIg) ± rituximab has been used in different regimens with contradictory results. Objective: To compare three regi...

Full description

Bibliographic Details
Main Authors: F Ahmadi, S Dashti-Khavidaki, M R Khatami, M Gatmiri, M Mahdavi-Mazdeh, M T Najafi, Z Foroozanfar, A Mahdizadeh, S Derafshi
Format: Article
Language:English
Published: Shiraz University of Medical Sciences 2019-07-01
Series:International Journal of Organ Transplantation Medicine
Subjects:
Antibody-mediated acute rejection
Intravenous immunoglobulin
Kidney transplantation
Plasmapheresis
Rituximab
Online Access:http://www.ijotm.com/ojs/index.php/IJOTM/article/view/523

Internet

http://www.ijotm.com/ojs/index.php/IJOTM/article/view/523

Similar Items